Lakefront Biotherapeutics NV 2019 SR
The report outlines Galapagos' sustainability strategy centered on four material pillars: improving lives, employee engagement, ethical business conduct, and environmental health and safety. In 2019, the company reached a milestone of over 1,000 employees and invested 427 million Euro in research and development. Key achievements included the regulatory submission of filgotinib and the establishment of a transformative R&D collaboration with Gilead. The company aligns its operations with eight UN Sustainable Development Goals and maintains a strong commitment to the Three Rs principle in animal welfare. Additionally, Galapagos implemented an EHS framework based on ISO 45001 and ISO 14001 standards.
Company: Lakefront Biotherapeutics NV
Sector: Professional & technical services
Country: Belgium
Year: 2019
Type: SR
Pages: 25
Back to company
Lakefront Biotherapeutics NV
CSR Report
The report outlines Galapagos' sustainability strategy centered on four material pillars: improving lives, employee engagement, ethical business conduct, and environmental health and safety. In 2019, the company reached a milestone of over 1,000 employees and invested 427 million Euro in research and development. Key achievements included the regulatory submission of filgotinib and the establishment of a transformative R&D collaboration with Gilead. The company aligns its operations with eight UN Sustainable Development Goals and maintains a strong commitment to the Three Rs principle in animal welfare. Additionally, Galapagos implemented an EHS framework based on ISO 45001 and ISO 14001 standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees